-+ 0.00%
-+ 0.00%
-+ 0.00%

RHYTHM PHARMACEUTICALS TO ANNOUNCE PRELIMINARY DATA FROM EXPLORATORY PHASE 2 TRIAL EVALUATING SETMELANOTIDE IN PRADER-WILLI SYNDROME

Reuters·12/10/2025 21:01:00

Please log in to view news